CCR2 and neoplasm: Similar findings were still encountered in the central nervous system, where the efficacy of αPD-1/4-1BB was maintained against CT2A-TRP2-β2mKO tumors implanted i.c. into Ccr2-KO mice, which have decreased tumor infiltration by peripheral macrophages17 (Extended Data Fig. 3b).